Shanghai Putuo District Central Hospital

Shanghai 200333

1 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Lipoprotein Disorder, Prevention of Stroke or Systemic Embolism

Studies at this site

• Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) — Recruiting now
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early